| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | CDK9 ZNF355P ZNF717 ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZFP3 ZNF334 ZNF607 ZNF566 ZNF816 MECOM ZNF525 ZNF578 NTN1 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZFP62 ZNF345 | 2.73e-16 | 1459 | 57 | 27 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | CDK9 ZNF355P ZNF717 ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZFP3 ZNF334 ZNF607 ZNF816 MECOM ZNF525 ZNF578 NTN1 ZNF880 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZFP62 ZNF345 | 8.30e-16 | 1244 | 57 | 25 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | CDK9 ZNF355P ZNF717 ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZFP3 ZNF334 ZNF607 ZNF816 MECOM ZNF525 ZNF578 NTN1 ZNF880 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZFP62 ZNF345 | 1.37e-15 | 1271 | 57 | 25 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF355P ZNF717 ZNF765 ZNF845 ZNF320 ZNF28 ZFP3 ZNF334 ZNF607 ZNF566 ZNF816 MECOM ZNF525 ZNF578 NTN1 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZFP62 ZNF345 | 1.54e-14 | 1412 | 57 | 25 | GO:0000981 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.03e-03 | 560 | 57 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.10e-03 | 566 | 57 | 7 | GO:0001216 | |
| GeneOntologyBiologicalProcess | cellular response to camptothecin | 7.20e-05 | 5 | 56 | 2 | GO:0072757 | |
| GeneOntologyBiologicalProcess | response to camptothecin | 7.20e-05 | 5 | 56 | 2 | GO:1901563 | |
| Domain | zf-C2H2_6 | ZNF765 ZNF845 ZNF320 ZNF613 ZNF334 ZNF607 ZNF566 ZNF816 MECOM ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZNF282 ZFP62 ZNF345 | 1.41e-23 | 314 | 55 | 21 | PF13912 |
| Domain | zf-C2H2 | ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZFP3 ZNF334 ZNF607 ZNF566 ZNF816 MECOM ZNF525 ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZNF282 ZFP62 ZNF345 | 2.64e-20 | 693 | 55 | 24 | PF00096 |
| Domain | - | ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZFP3 ZNF334 ZNF607 ZNF566 ZNF816 MECOM ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZNF282 ZFP62 ZNF345 | 3.39e-19 | 679 | 55 | 23 | 3.30.160.60 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZFP3 ZNF334 ZNF607 ZNF566 ZNF816 MECOM ZNF525 ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZNF282 ZFP62 ZNF345 | 3.53e-19 | 775 | 55 | 24 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZFP3 ZNF334 ZNF607 ZNF566 ZNF816 MECOM ZNF525 ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZNF282 ZFP62 ZNF345 | 3.74e-19 | 777 | 55 | 24 | PS00028 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZFP3 ZNF334 ZNF607 ZNF566 ZNF816 MECOM ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZNF282 ZFP62 ZNF345 | 5.50e-19 | 694 | 55 | 23 | IPR013087 |
| Domain | Znf_C2H2 | ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZFP3 ZNF334 ZNF607 ZNF566 ZNF816 MECOM ZNF525 ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZNF282 ZFP62 ZNF345 | 8.46e-19 | 805 | 55 | 24 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZFP3 ZNF334 ZNF607 ZNF566 ZNF816 MECOM ZNF525 ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZNF282 ZFP62 ZNF345 | 9.22e-19 | 808 | 55 | 24 | SM00355 |
| Domain | KRAB | ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZNF334 ZNF607 ZNF566 ZNF816 ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF282 | 6.03e-18 | 358 | 55 | 18 | PS50805 |
| Domain | KRAB | ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZNF334 ZNF607 ZNF566 ZNF816 ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF282 | 6.03e-18 | 358 | 55 | 18 | PF01352 |
| Domain | KRAB | ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZNF334 ZNF607 ZNF566 ZNF816 ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF282 | 1.03e-17 | 369 | 55 | 18 | SM00349 |
| Domain | KRAB | ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZNF334 ZNF607 ZNF566 ZNF816 ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF282 | 1.08e-17 | 370 | 55 | 18 | IPR001909 |
| Domain | Znf_C2H2-like | ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZFP3 ZNF334 ZNF607 ZNF566 ZNF816 MECOM ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZNF282 ZFP62 ZNF345 | 1.14e-17 | 796 | 55 | 23 | IPR015880 |
| Domain | PLAC | 8.60e-06 | 14 | 55 | 3 | PF08686 | |
| Domain | PLAC | 2.26e-05 | 19 | 55 | 3 | IPR010909 | |
| Domain | PLAC | 2.26e-05 | 19 | 55 | 3 | PS50900 | |
| Domain | Galactose-bd-like | 1.69e-04 | 94 | 55 | 4 | IPR008979 | |
| Domain | EGF | 6.30e-04 | 235 | 55 | 5 | SM00181 | |
| Domain | BBOX | 1.10e-03 | 69 | 55 | 3 | SM00336 | |
| Domain | - | 1.20e-03 | 71 | 55 | 3 | 4.10.45.10 | |
| Domain | zf-B_box | 1.25e-03 | 72 | 55 | 3 | PF00643 | |
| Domain | - | 1.30e-03 | 73 | 55 | 3 | 2.60.120.260 | |
| Domain | Znf_C3HC4_RING-type | 1.64e-03 | 172 | 55 | 4 | IPR018957 | |
| Domain | ZF_BBOX | 1.69e-03 | 80 | 55 | 3 | PS50119 | |
| Domain | Znf_B-box | 1.75e-03 | 81 | 55 | 3 | IPR000315 | |
| Domain | ADAM_spacer1 | 2.07e-03 | 23 | 55 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.07e-03 | 23 | 55 | 2 | PF05986 | |
| Domain | zf-C3HC4 | 4.19e-03 | 223 | 55 | 4 | PF00097 | |
| Domain | EGF-like_dom | 6.18e-03 | 249 | 55 | 4 | IPR000742 | |
| Domain | EGF_1 | 6.71e-03 | 255 | 55 | 4 | PS00022 | |
| Domain | PRY | 6.80e-03 | 42 | 55 | 2 | PF13765 | |
| Domain | EGF-like_CS | 7.27e-03 | 261 | 55 | 4 | IPR013032 | |
| Domain | EGF_2 | 7.67e-03 | 265 | 55 | 4 | PS01186 | |
| Domain | PRY | 8.81e-03 | 48 | 55 | 2 | SM00589 | |
| Domain | PRY | 8.81e-03 | 48 | 55 | 2 | IPR006574 | |
| Domain | ZF_RING_1 | 1.06e-02 | 291 | 55 | 4 | PS00518 | |
| Domain | ZF_RING_2 | 1.14e-02 | 298 | 55 | 4 | PS50089 | |
| Domain | Channel_four-helix_dom | 1.23e-02 | 57 | 55 | 2 | IPR027359 | |
| Domain | - | 1.23e-02 | 57 | 55 | 2 | 1.20.120.350 | |
| Domain | Znf_RING_CS | 1.23e-02 | 163 | 55 | 3 | IPR017907 | |
| Domain | RING | 1.24e-02 | 305 | 55 | 4 | SM00184 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | CDK9 ZNF717 ZNF320 ZNF28 ZNF613 ZNF334 ZNF607 ZNF566 CHEK2 ZNF749 ZNF761 ZNF860 ZNF468 ZNF606 ZNF282 | 5.51e-06 | 1387 | 42 | 15 | M734 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | 2.81e-04 | 107 | 42 | 4 | M48260 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 3.54e-04 | 768 | 42 | 9 | MM14851 | |
| Pubmed | 6.12e-10 | 181 | 57 | 8 | 37372979 | ||
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 1.30e-06 | 49 | 57 | 4 | 9630514 | |
| Pubmed | Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1(high) leukemia cells. | 2.64e-06 | 2 | 57 | 2 | 22033412 | |
| Pubmed | 6.29e-06 | 22 | 57 | 3 | 31403225 | ||
| Pubmed | Four human chromosome 3q and four human chromosome 21 loci map onto sheep chromosome 1q. | 5.51e-05 | 7 | 57 | 2 | 7749229 | |
| Pubmed | 9.54e-05 | 451 | 57 | 6 | 36168627 | ||
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 15889140 | ||
| Pubmed | 1.72e-04 | 12 | 57 | 2 | 1797234 | ||
| Pubmed | 1.72e-04 | 12 | 57 | 2 | 33251042 | ||
| Pubmed | 2.73e-04 | 15 | 57 | 2 | 15885501 | ||
| Pubmed | The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. | 3.53e-04 | 17 | 57 | 2 | 23502783 | |
| Pubmed | 3.97e-04 | 18 | 57 | 2 | 23077300 | ||
| Pubmed | TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. | 5.43e-04 | 21 | 57 | 2 | 18248090 | |
| Pubmed | 6.95e-04 | 105 | 57 | 3 | 22493164 | ||
| Pubmed | 7.12e-04 | 24 | 57 | 2 | 30796970 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 7.35e-04 | 1203 | 57 | 8 | 29180619 | |
| Pubmed | 1.04e-03 | 29 | 57 | 2 | 14563677 | ||
| Pubmed | 1.43e-03 | 34 | 57 | 2 | 32152128 | ||
| Interaction | LTBP2 interactions | 1.44e-07 | 85 | 57 | 6 | int:LTBP2 | |
| Interaction | ZNF467 interactions | 7.05e-07 | 179 | 57 | 7 | int:ZNF467 | |
| Interaction | PURG interactions | 3.89e-05 | 223 | 57 | 6 | int:PURG | |
| Interaction | TRIM28 interactions | CDK9 ZNF765 ZNF845 ZNF320 ZNF28 ZNF607 ZNF566 CHEK2 ZNF816 ZNF749 ZNF761 ZNF84 ZNF468 ZNF107 | 4.57e-05 | 1474 | 57 | 14 | int:TRIM28 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | LENG8 ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZNF607 ZNF566 ZNF816 ZNF525 ZNF578 ZNF880 ZNF749 ZNF761 FBXO17 ZNF468 ZNF606 ZNF345 | 3.03e-15 | 1192 | 57 | 18 | chr19q13 |
| Cytoband | 19q13.41 | 7.66e-12 | 78 | 57 | 7 | 19q13.41 | |
| Cytoband | 19q13.42 | 5.16e-07 | 125 | 57 | 5 | 19q13.42 | |
| Cytoband | 19q13.12 | 3.66e-03 | 72 | 57 | 2 | 19q13.12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF717 ZNF765 ZNF845 ZNF320 ZNF28 ZNF613 ZFP3 ZNF334 ZNF607 ZNF566 ZNF816 MECOM ZNF525 ZNF578 ZNF880 ZNF749 ZNF761 ZNF84 ZNF860 ZNF468 ZNF606 ZNF107 ZNF282 ZFP62 ZNF345 | 1.97e-23 | 718 | 46 | 25 | 28 |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.81e-03 | 95 | 46 | 3 | 59 | |
| GeneFamily | Ring finger proteins | 5.18e-03 | 275 | 46 | 4 | 58 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-06 | 175 | 57 | 5 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.94e-06 | 194 | 57 | 5 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.46e-06 | 198 | 57 | 5 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.46e-06 | 198 | 57 | 5 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.46e-06 | 198 | 57 | 5 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Intermediate|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.17e-05 | 109 | 57 | 4 | 48f675d36fece070410eb9cfe64805f4629e290f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 153 | 57 | 4 | 0a4fbe46125b05ee235deb528855808c2bf33cba | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-05 | 154 | 57 | 4 | 71d33b5dbfab5820e3daddb01806a69116ba8008 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.76e-05 | 156 | 57 | 4 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 5.38e-05 | 161 | 57 | 4 | 537a1d86de99a493b0345ca0f760994260e97049 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 8.29e-05 | 180 | 57 | 4 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.47e-05 | 181 | 57 | 4 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.22e-05 | 185 | 57 | 4 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.22e-05 | 185 | 57 | 4 | 62cfcb0e2a9e6718e6b200dfbb1a81eaead229b5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-05 | 186 | 57 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 9.41e-05 | 186 | 57 | 4 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.81e-05 | 188 | 57 | 4 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.81e-05 | 188 | 57 | 4 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-04 | 189 | 57 | 4 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 190 | 57 | 4 | 2434b8ad2976eab7d9147012c28454ab29670709 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 191 | 57 | 4 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.04e-04 | 191 | 57 | 4 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 191 | 57 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 191 | 57 | 4 | 89d03c4133dda852a3713c0902a7d67941cf5b21 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.04e-04 | 191 | 57 | 4 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 192 | 57 | 4 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | Healthy_donor-B_intermediate|World / disease group, cell group and cell class (v2) | 1.06e-04 | 192 | 57 | 4 | f77007b284e11f8654ad599eef929df7c6c4ebf0 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 195 | 57 | 4 | 44f67437ea65d530133a0240b17f9860d9cc0e99 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-04 | 195 | 57 | 4 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | 15-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 1.15e-04 | 196 | 57 | 4 | 0e45817625b96d21a8cc4dfbbd465ee6403b6802 | |
| ToppCell | 15-Distal-Mesenchymal|Distal / Age, Tissue, Lineage and Cell class | 1.15e-04 | 196 | 57 | 4 | b8d95b5f4780e73d16dcc528e70a5496f0314373 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-04 | 197 | 57 | 4 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-04 | 197 | 57 | 4 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-04 | 197 | 57 | 4 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-04 | 197 | 57 | 4 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.20e-04 | 198 | 57 | 4 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 1.20e-04 | 198 | 57 | 4 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 199 | 57 | 4 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.22e-04 | 199 | 57 | 4 | fcbb3a9c0f4c5b4c1f09db24b9f50cc1166fa43b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.24e-04 | 200 | 57 | 4 | 482dfbbd8958b64c31568dccbffe3cc9589f876b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | wk_15-18-Mesenchymal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.24e-04 | 200 | 57 | 4 | 4d484260ecbbbd9f820b445bdcc2666f6c464b73 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.24e-04 | 200 | 57 | 4 | 4f624c3c57d1a84baa86d0830cb1b83ae110bf67 | |
| ToppCell | wk_08-11-Mesenchymal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.24e-04 | 200 | 57 | 4 | 91416639e69621c5b36eebf061d81bccfe66f135 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | wk_20-22-Mesenchymal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.24e-04 | 200 | 57 | 4 | 5c8557d2c414d8a8c518270f8c045b53cae45fb6 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.20e-04 | 114 | 57 | 3 | 670c9802a59b39241abf6f2c12a3d1844c7db5e5 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.99e-04 | 121 | 57 | 3 | 4ec70ad316942d9ade7bbdbf0e117e7c52b59d90 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-9|TCGA-Kidney / Sample_Type by Project: Shred V9 | 6.43e-04 | 132 | 57 | 3 | f1ef63a4842ab6ca584a9dcc2dd5b2108fc990aa | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.72e-04 | 134 | 57 | 3 | 8707210b2a5d33baa1d204e9e2ed8921181cb309 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.72e-04 | 134 | 57 | 3 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-04 | 135 | 57 | 3 | 52b5c664c0b7a303c6084d508748dcb6c38a0c23 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-04 | 137 | 57 | 3 | b831d917f5073ccff158662adb281d34f023126a | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.17e-04 | 137 | 57 | 3 | 81cdb216e6c81acf9c2072f9d39e1a42612e1258 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-04 | 137 | 57 | 3 | cf3e928d9a7a7349840bb87475a42a07f65b94f0 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-04 | 137 | 57 | 3 | 5d82d6c7eef4ec7a7fae60e37fb956488314987e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Mesoderm|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 7.47e-04 | 139 | 57 | 3 | d441c29852c28928ecb696b4b95e31b30c17116b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.61e-04 | 146 | 57 | 3 | 159dd157a74f3c27dc1a1dcbbf0ed8f9462cac9e | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9 | 9.14e-04 | 149 | 57 | 3 | 89705865e94360c1288ee98c5a6b381f3c6242b3 | |
| ToppCell | Nasal_Brush-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.31e-04 | 150 | 57 | 3 | d39d73a1de6a873292d48e469d9403f513045be3 | |
| ToppCell | Nasal_Brush-Epithelial-Club|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.31e-04 | 150 | 57 | 3 | c68645ffcffe524cf1d9736cf72a15b37ed8dc3d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.31e-04 | 150 | 57 | 3 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 9.49e-04 | 151 | 57 | 3 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-03 | 156 | 57 | 3 | ff39712c7a2dc1b85c598d5105789aa291dea726 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.06e-03 | 157 | 57 | 3 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-03 | 158 | 57 | 3 | 1bf692f1e85f677cd62805437b7a59cfaf3b0449 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-03 | 158 | 57 | 3 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-dnT|Bac-SEP / Disease, Lineage and Cell Type | 1.12e-03 | 160 | 57 | 3 | f5ca49801c981b903a85a64b21ece6b59fe91cbc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-03 | 160 | 57 | 3 | 1e210e526ea4d84fc58a798a26c0929bcb69fd89 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-03 | 161 | 57 | 3 | f470b662566131dfe69a2fd01186ac8491196396 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.14e-03 | 161 | 57 | 3 | aee74a2e7a8acd2950341963f1c04b59c7862183 | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-03 | 161 | 57 | 3 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.18e-03 | 163 | 57 | 3 | edca1d1a345109dbdeb7ee5464faefab1993fdb2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-03 | 164 | 57 | 3 | 83141be8dfed85511ea6afda7c76ff4b6b5ef021 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.20e-03 | 164 | 57 | 3 | 3d8ff70fe5582d1fb56b338be8b76fa1428b3657 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-03 | 164 | 57 | 3 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-03 | 164 | 57 | 3 | d6806deabf5f5c355934387be2baae125ac33fb8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-03 | 165 | 57 | 3 | 9bd332e5ede759a00a47728ea5558c215efdd77a | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-03 | 165 | 57 | 3 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.23e-03 | 165 | 57 | 3 | 8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-03 | 165 | 57 | 3 | a6c6de17fec678ad0cac3138dde3a14cc39ffd26 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-03 | 165 | 57 | 3 | 9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-03 | 166 | 57 | 3 | 971ee6602a1e751f453f9d823295e63dadce62bf | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-03 | 167 | 57 | 3 | d041b345014e170e9a45f8c6ef8a37ff56f14750 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-03 | 167 | 57 | 3 | edc5f04584b44f99ff9a62bbe0dab6fc044fb334 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 1.29e-03 | 168 | 57 | 3 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.29e-03 | 168 | 57 | 3 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-03 | 169 | 57 | 3 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-03 | 169 | 57 | 3 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-03 | 169 | 57 | 3 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-03 | 169 | 57 | 3 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-03 | 171 | 57 | 3 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-03 | 171 | 57 | 3 | 3d60e7ecf25e4b781ba2387671b2aad247fb75ff | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue | 1.38e-03 | 172 | 57 | 3 | 243b8bb01cbec5c1bf8802cbf8a6153356b4c384 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 5.43e-06 | 20 | 51 | 3 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | vascular endothelial function measurement | 2.64e-05 | 99 | 51 | 4 | EFO_0803369 | |
| Disease | hypertension (is_marker_for) | 1.07e-04 | 53 | 51 | 3 | DOID:10763 (is_marker_for) | |
| Disease | brain measurement, neuroimaging measurement | 3.61e-04 | 550 | 51 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | glomerulonephritis (is_marker_for) | 4.92e-04 | 19 | 51 | 2 | DOID:2921 (is_marker_for) | |
| Disease | myeloproliferative disorder | 8.57e-04 | 25 | 51 | 2 | EFO_0004251 | |
| Disease | Antiglaucoma preparations and miotics use measurement | 9.27e-04 | 26 | 51 | 2 | EFO_0009944 | |
| Disease | Pancytopenia | 9.27e-04 | 26 | 51 | 2 | C0030312 | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 1.49e-03 | 33 | 51 | 2 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QDYDECERKEDDCVP | 896 | Q5DID0 | |
| KIPKDCDRYDDLCSY | 331 | Q8TCU4 | |
| SKEKEYVPFQAECEC | 1681 | Q96DT5 | |
| KREEEKPFRDCADVY | 276 | Q15389 | |
| CEYCFDEPLLKRTDK | 121 | O96017 | |
| VEEPEDCDSYCKASK | 466 | O95631 | |
| YHDVKEICKCDVDEF | 291 | Q9H714 | |
| PREAEDCEDYSKCYV | 1076 | Q8TE59 | |
| EKDSMIFDCTECYDP | 351 | Q9Y573 | |
| TEEREYKCDQCPKAF | 286 | Q03112 | |
| EIIGDCCYEEYKDRK | 126 | Q9UK17 | |
| CCYEEYKDRKRENAE | 131 | Q9UK17 | |
| YVERCFTACESEEDK | 296 | Q96PV6 | |
| CPEKTYSEEVECKAC | 1071 | Q92824 | |
| VSCCKDPEIDFKEFE | 66 | Q8IWU2 | |
| KCEIIKEFPEVYFCE | 681 | Q8NB91 | |
| EKEQCPYTSEDECIK | 1451 | Q460N5 | |
| EDKEEFPLCALARYC | 86 | Q96EF6 | |
| DFKYDCPDKSDEASC | 1071 | Q5VYJ5 | |
| KCYRCSEAVFKEELP | 811 | O60308 | |
| KREKPYCLDIDECAS | 126 | Q6UXH8 | |
| FTYSLLPEDCKEEKC | 331 | P03952 | |
| DSVECPFCDEVSKYE | 6 | P50750 | |
| CEKHREPLKLYCEED | 96 | P14373 | |
| KEELLCAVCYDPFRD | 16 | Q9UPQ4 | |
| FKKGDEYDVCAICLD | 231 | O43567 | |
| FSKFYPCEECAEDLR | 136 | P55789 | |
| EKPYKCEECDEAFSF | 436 | Q96IR2 | |
| GEKPYKCEECDEAFS | 491 | Q96IR2 | |
| GEKPYKCEECDEAFS | 631 | Q96IR2 | |
| TGEKPYKCEECDEAF | 406 | Q8N782 | |
| EEAVCAICLDYFKDP | 16 | Q96A61 | |
| GEKPYKCEECDRAFS | 436 | Q9UII5 | |
| EKPYRCDECGKDFTR | 461 | Q6PDB4 | |
| EKPYKCEECDKAFRV | 631 | Q86XN6 | |
| EKPYRCEECDKVFSR | 326 | A2RRD8 | |
| GEKSYKCEECDRVFS | 451 | Q96N58 | |
| RPYECTECEKAFVRK | 436 | O43361 | |
| RPYECSECRKTFIDK | 291 | Q9HCZ1 | |
| CLDNTRKPVDEYKDC | 246 | P02787 | |
| KEDSEKTCEVYCPDI | 391 | Q14159 | |
| CITRFFEECDPNKDK | 626 | Q14515 | |
| EPEACFTEDCVRKFK | 1166 | Q99250 | |
| REKPYECEECGKVFS | 166 | Q96SK3 | |
| TGEKPYECRDCEKAF | 566 | P51523 | |
| EKPYECSLCRKAFFE | 596 | P51523 | |
| SGEKPYECDECRKTF | 781 | Q9BY31 | |
| GEKPYECTECDKAFR | 256 | Q6PF04 | |
| EKPYECKECEKAFRS | 336 | Q969W8 | |
| DKPYECEECDKVFSR | 296 | P17035 | |
| KPYECEECEKVFSRK | 381 | P17035 | |
| REKPYECDRCEKVFR | 641 | Q8NB50 | |
| QKPYKCEDCDEAFSF | 491 | Q7L2R6 | |
| TEEKPYKCEECVRVF | 386 | Q9NSJ1 | |
| EKPYKCEECDKVFSR | 311 | A6NHJ4 | |
| EKPYECKECEKAFRS | 311 | Q14585 | |
| DCVPEVDENCKDKYY | 966 | Q6ZMP0 | |
| EKPYECEECDKVFSR | 296 | Q5VIY5 | |
| TKERPYECAECEKSF | 541 | Q9UDV7 | |
| EKPYKCEECDKVFSR | 506 | Q0VGE8 | |
| KCDECEKAFRDYSAL | 541 | Q8WXB4 | |
| EKPYECSECEKTFSQ | 446 | Q96NJ6 |